Page last updated: 2024-11-02

oxophenylarsine and Reperfusion Injury

oxophenylarsine has been researched along with Reperfusion Injury in 2 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandau, KB1
Zhou, J1
Kietzmann, T1
Brüne, B1
Kristian, T1
Bernardi, P1
Siesjö, BK1

Other Studies

2 other studies available for oxophenylarsine and Reperfusion Injury

ArticleYear
Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide.
    The Journal of biological chemistry, 2001, Oct-26, Volume: 276, Issue:43

    Topics: Androstadienes; Arsenicals; Deferoxamine; Genistein; Hypoxia-Inducible Factor 1, alpha Subunit; Infl

2001
Acidosis promotes the permeability transition in energized mitochondria: implications for reperfusion injury.
    Journal of neurotrauma, 2001, Volume: 18, Issue:10

    Topics: Acidosis; Animals; Arsenicals; Brain; Calcium; Energy Metabolism; Enzyme Inhibitors; Hydrogen-Ion Co

2001